The vagus nerve is the heart’s primary brake. Through its cardiac branches, it releases acetylcholine at the sinoatrial and atrioventricular nodes, slowing heart rate and conduction velocity. When vagal input is excessive, insufficient, or poorly timed, the result can be an irregular heartbeat — ranging from benign ectopic beats to clinically significant arrhythmias. Understanding the specific mechanisms by which the vagus nerve influences cardiac rhythm explains both why certain arrhythmias occur and why vagus nerve stimulation is being developed as a treatment for heart disease.
How the Vagus Nerve Controls Heart Rhythm
The heart generates its own electrical rhythm through the SA node (the natural pacemaker), but the autonomic nervous system constantly modulates that rhythm. The sympathetic nervous system accelerates heart rate; the vagus nerve decelerates it. This push-pull system allows heart rate to respond instantly to changing demands — accelerating during exercise, decelerating during sleep.
Vagal influence on the heart operates through two main mechanisms. First, acetylcholine released at the SA node activates muscarinic receptors that hyperpolarise pacemaker cells, slowing their spontaneous firing rate. Second, acetylcholine at the AV node slows conduction, increasing the delay between atrial and ventricular contraction. This dual action means vagal activity simultaneously affects heart rate (chronotropy) and conduction speed (dromotropy).
Heart rate variability (HRV) — the beat-to-beat variation in heart rate — is primarily a measure of vagal cardiac modulation. Higher HRV generally indicates stronger vagal tone and healthier autonomic balance. Reduced HRV is an independent risk factor for cardiovascular mortality and has been documented in heart failure, post-myocardial infarction, diabetes, and depression.
Vagotonic Atrial Fibrillation
One of the most clinically significant links between the vagus nerve and arrhythmia is vagotonic (or vagally mediated) atrial fibrillation. This form of AF typically occurs in younger, otherwise healthy individuals — often male — and follows a distinctive pattern: episodes are triggered at rest, during sleep, or after large meals, precisely when vagal tone is highest. This contrasts with adrenergic AF, which is triggered by exercise or emotional stress.
The mechanism involves vagal shortening of the atrial refractory period. Acetylcholine activates potassium channels (IKACh) in atrial cells, shortening their action potential duration. When different atrial regions experience different levels of vagal input, the resulting dispersion of refractoriness creates the conditions for re-entrant circuits — the electrical disorganisation that defines atrial fibrillation.
Recognising vagotonic AF matters clinically because it responds differently to treatment. Beta-blockers, which are first-line for adrenergic AF, can actually worsen vagotonic AF by removing sympathetic opposition to vagal effects. Vagotonic AF may respond better to disopyramide (which has anticholinergic properties) or flecainide. Lifestyle modifications include avoiding large late meals, excessive alcohol, and supine positions after eating.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,684 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- HRV biofeedback
- Polyvagal-informed therapy
- Somatic therapy
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
VNS for Heart Failure: The ANTHEM-HFrEF Trial
Paradoxically, while excessive vagal activity can trigger certain arrhythmias, insufficient vagal tone contributes to the progression of heart failure. Heart failure is characterised by sympathetic over-activation and vagal withdrawal — a combination that drives harmful cardiac remodelling, inflammation, and arrhythmia risk.
The ANTHEM-HFrEF (Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure) trial investigated implantable vagus nerve stimulation as a treatment for heart failure with reduced ejection fraction. The trial demonstrated improvements in cardiac function (measured by ejection fraction), exercise capacity, and quality of life in patients receiving chronic VNS. The proposed mechanism is that VNS restores autonomic balance — increasing vagal tone and reducing sympathetic over-activation — which slows harmful remodelling and reduces the inflammatory state that drives heart failure progression.
Research into closed-loop VNS systems that adjust stimulation in real time based on cardiac sensing is ongoing. These systems aim to deliver vagal stimulation that responds dynamically to the heart’s needs rather than applying fixed-parameter stimulation.
Other Vagally Mediated Arrhythmias
Sinus bradycardia. Strong vagal tone slows the SA node below 60 beats per minute. This is normal in athletes and during sleep but can become symptomatic (dizziness, fatigue, syncope) if heart rate drops too low. Extreme vagal bradycardia can produce pauses long enough to cause near-syncope.
AV block. High vagal tone can produce first-degree AV block (prolonged PR interval) or second-degree AV block (Wenckebach type). Vagally mediated AV block typically occurs during sleep or rest and resolves with exercise or atropine (which blocks vagal effects). It is generally benign and does not require pacing unless it produces persistent symptoms.
Vasovagal syncope. The classic fainting episode involves a sudden vagal surge that produces both bradycardia and peripheral vasodilation, crashing blood pressure and cerebral perfusion. The arrhythmia component is the abrupt bradycardia or asystole (brief cardiac standstill) that often accompanies the vasodepressor response.
Measuring Vagal Cardiac Influence
HRV analysis is the standard non-invasive measure of cardiac vagal tone. The high-frequency component of HRV (HF-HRV, 0.15-0.4 Hz) is specifically associated with vagal modulation and reflects respiratory sinus arrhythmia — the normal variation in heart rate with breathing. Reduced HF-HRV indicates diminished vagal cardiac influence and is associated with increased cardiovascular risk. Wearable devices that measure HRV provide accessible, if less precise, estimates of vagal tone over time.
The vagus nerve is the single most important neural regulator of your heart rhythm — and understanding it changes how you interpret what your heart is doing. Get the Vagus Nerve & Me eBook for the complete guide to the nerve that connects your brain and your heart.




